Search Results 2641-2650 of 19799 for CLL
-
James E. Colletti, M.D., is a primary investigator on multiple studies in the field of medical education. Focus areas. Interview and recruitment processes for ...
-
Cirrhosis is a scarring of the liver that damages function and can be life-threatening. Almost half of all cirrhosis deaths are attributed to chronic alcohol ...
-
Managing chronic lung rejection. Here's a closer look at the focus areas. Improving HLA antibody testing. Mayo Clinic lung transplant researchers are working to ...
-
Dr. Cliby's research in clinical outcomes focuses on treatment of ovarian cancer with a specific interest in surgical management. Dr. Cliby leads multiple ...
-
A new treatment option for certain colorectal cancer patients whose cancer has spread to their liver and are ineligible for other surgical options.
-
Faculty members conducting research through the Center for Multiple Sclerosis and Autoimmune Neurology at Mayo Clinic have wide-ranging expertise.
-
The purpose of this clinical trial is to evaluate efficacy and safety of tirabrutinib alone compared with rituximab and temozolomide (R-TMZ) combination therapy ...
-
Klarich, M.D., has an interest in structural heart disease, cardiomyopathies, tumors (neoplasms) of the heart and valvular heart disease. Focus areas. Papillary ...
-
Lifileucel injection is used to treat melanoma (skin cancer) that has spread or cannot be removed by surgery. This medicine is given to patients who have ...
-
ROCHESTER, Minn. — Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, ...